128 filings
8-K
IKT
Inhibikase Therapeutics Inc
30 Apr 24
Regulation FD Disclosure
8:17am
S-1/A
IKT
Inhibikase Therapeutics Inc
IPO registration (amended)
29 Apr 24
4:33pm
DEFA14A
IKT
Inhibikase Therapeutics Inc
26 Apr 24
Additional proxy soliciting materials
4:30pm
ARS
2023 FY
IKT
Inhibikase Therapeutics Inc
26 Apr 24
Annual report to shareholders
4:20pm
DEF 14A
IKT
Inhibikase Therapeutics Inc
Definitive proxy
26 Apr 24
4:15pm
8-K
2kh6c8wy
18 Apr 24
Inhibikase Therapeutics Issues Letter to Shareholders and Provides Update on Development Programs
9:46pm
8-K/A
msrm9jdni 83kc
2 Apr 24
Departure of Directors or Certain Officers
5:12pm
8-K
hqna76rmkb7 u1bj4c
7 Feb 24
Inhibikase Therapeutics Announces Preliminary Outcomes of its Pre-NDA
7:59am
424B5
cyx 7mo2ja46
1 Feb 24
Prospectus supplement for primary offering
4:49pm
8-K
i62eg8c ak5
1 Feb 24
Entry into a Material Definitive Agreement
4:09pm
8-K
kl61xo v3
16 Jan 24
Inhibikase Therapeutics Announces Planned Retirement of Chief Financial Officer Joseph Frattaroli
4:31pm
8-K
4chsv
20 Sep 23
Inhibikase Therapeutics Issues a Letter to Shareholders and Comments on Recent Trading Activity
11:23am
8-K
mi9j raex
17 Jul 23
Other Events
5:29pm